Narender Dev  Mantena 

Head, Global Strategy and CEO, Biological E. Limited  

Mr. Narender Mantena has been associated with Biological E. Limited since 1992. He has been responsible for forging key alliances with GSK, Merck and Intercell. He laid the road map for the company’s foray into the regulated markets. He also championed the complex/routine injectables, novel vaccines and synthetic biology initiatives at Biological E. Limited. Mr. Mantena holds a master’s degree in Engineering from Michigan State University.